Phenotype Assays
Welcome to the MMPC Phenotype Assay search page. Select a Phenotype Assay Group to limit search results to a specific type of assay. You may also specify a name and / or abbreviation to search for. To list assays specific only to MMPC check the box next to MMPC specific.
Click here to filter search results...
Click here to close / hide filter...
Group
[Any]
albuminuria assays
basic vital measurements
behavioral assessment of sensation
body composition
cardiac function assays
cardiovascular
cognitive function
diabetes evaluation assays
energy balance & excercise
energy expenditure
enzymes
experimental parameters
food intake
glomerular filtration rate assays
glucose & insulin metabolism
histology assays
hormones/cytokines
inflammation assays
kidney
lipid metabolism assays
lipids and lipoproteins
lymphatics
metabolic flux
metabolites
morphometry
nerve conduction assays
serum chemistry
MMPC Specific
Check this box if the assay is MMPC specific...
Name
Contains
Starts With
Abbreviation
Contains
Starts With
Catalog Items (Tests)
[None Selected]
University of California Davis
University of Cincinnati Medical Center
University of Massachusetts Medical School
University of Michigan Medical School
Vanderbilt University School of Medicine
(optional: Filter Tests by Center)
[None Selected]
C1041: Body Composition / Carcass Analysis (per animal)
C1042: Energy Expenditure Measurements
C1052: Lipid Profiles (TG, CHOL, PL, NEFA)(per set of 38 samples)
C1054: Lipoprotein fractionation by FPLC (per sample)
C1057: Free Fatty Acids (NEFA) Concentration (per set of 38 samples)
C1085: Glucagon concentration (per set of 38 samples)
C1087: Glucose concentration (per set of 38 samples)
C1089: Insulin Assay (per set of 38 samples)
C1090: Leptin concentration (per set of 38 samples)
C1092: Triglyceride concentration (per set of 38 samples)
V3002: Jugular vein and carotid artery catheterization
V3003: Glucose Tolerance Test (Oral, i.p., Intravenous, or gastric catheter)
V3004: Glucose turnover
V3005: Hyperinsulinemic clamp
V3006: Hyperglycemic clamp
V3007: Gluconeogenesis & glycogenolysis (from hepatic 14C-UDPglucose and PEP)
V3008: Glycogen synthesis
V3010: Tissue specific glucose uptake
V3011: Tissue specific fatty acid uptake
V3012: Indirect calorimetry / energy expenditure in the Promethion
V3013: Exercise capacity/Exercise Stress Test (metabolic response to exercise)
V3014: Spontaneous exercise activity
V3015: Food Consumption
V3016: Exploratory locomotor activity
V3017: Assess real time imaging of cellular metabolic events
V3030: In vitro Morphology, Morphometrics and Histology (isolated heart)
V3031: Echocardiography, in vivo morphology, systolic and diastolic function; Stress echocardiography
V3033: Blood pressure measurements
V3036: Tail vein injections
V3050: Insulin
V3051: Glucagon
V3052: Corticosterone
V3053: Catecholamines
V3054: Leptin
V3055: C-Peptide
V3070: Plasma lipids
V3073: Quantitation of individual phospholipid classes
V3081: Tissue preparation, embedding, sectioning and routine staining
V3082: Tissue microdissection
V3093: Specific activities for gluconeogenic and glycogenic assessment
C1044: Meal Pattern Analysis - Food Intake Procedure
C1058: ß-hydroxybutyrate concentration (per set of 38 samples)
C1059: Non-invasive measurement of intestinal fat absorption (each)
C1061: Adiponectin concentration (per set of 38 samples)
C1083: Cholesterol (total) (per set of 38 samples)
V3062: Aldosterone
V3065: Adiponectin
V3000A: Miscellaneous Tissue and Body Fluid Collection
V3000F: Jugular Vein or Carotid Artery Catheterization
C1104: Lipid extraction via folch (per set of 12 samples)
C1108: Multiplexing assays (+ kit costs-C1114) (per plate)
D2001: Importation of Mice and Material
D2002: Per Diem
D3101: Intravenous Glucose Tolerance Test
D3301: Lipid extraction from liver
D3302: Lipid extraction from muscle
D3401: Glucose (urine/plasma)
D3402: Hemoglobin A1C
D3403: beta-OH butyrate
D3404: Triglyceride
D3405: Total Cholesterol
D3406: HDL-C and LDL-C/VLDL-C
D3407: HDL-TG and LDL-TG/VLDL-TG
D3408: Non esterified fatty acids
D3410: Lipoprotein profiling
D3412: Metabolomics
D3413: Complex lipid ratios
D3431: Hormones - Generic ELISA Assay
D3432: Insulin
D3435: Leptin
D3436: Adiponectin (total)
D3437: Adiponectin (HMW)
D3438: Glucagon
D3440: Glucagon-like peptide 1 (total)
D3441: Ghrelin
D3461: Markers of Inflammation - custom panel
D3462: Markers of Inflamation - limited panel
D3463: HS CRP
D3482: Protein Carbonyl (plasma, cell lysates, tissue homogenates)
D3483: Catalase (plasma, cell lysates, tissue homogenates)
D3485: Glutathione Peroxidase
D3486: Glutathione Reductase
D3488: Superoxide Dismutase
D3491: Insulin Signalling pathway
D4001: Gross Body Composition
D4002: Adiposity (adipose depot weights)
D4006-A: Gut Microbiome Analysis (454 method-3000 avg seq read depth)
D4007: Energy Expenditure (CLAMS, Indirect Calorimetry)
D5003: Lipoprotein analysis by LTRS
D5006-A: BP & heart rate variability measurements by telemetry
D5009: Cardiac electrophysiology
D5010: Echocardiography
D2013: MMPC mouse gross necropsy with histology (Level 1)
D5014-A: Advanced Mouse Pathology
M1001: Hyperinsulinemic-euglycemic clamp
M1002: Basal glucose metabolism
M1003: Organ-specific glucose uptake
M1004: Hyperglycemic clamp
M1006: Glucose tolerance test
M1007: Glucose tolerance test with insulin secretion
M1008: Insulin tolerance test
M1009: Hepatic gluconeogenesis
M1010: Lipid metabolism
M1012: Body composition (whole body)
M1014: Energy balance – food intake, energy expenditure, physical activity
M1015: Chronic high-fat feeding
M1016: Chronic drug delivery
M1018: Acute lipid infusion
M1020: Exercise study using cage running wheels
M1021: Surgery – jugular vein cannulation
M1022: Surgery – tail vein injection
M2001: Glucose
M2002: Hemoglobin A1c
M2003: Lactate
M2004: Insulin
M2005: C-peptide
M2006: Glucagon
M2007: Leptin
M2008: Adiponectin
M2009: Resistin
M2010: Triglyceride
M2011: Non-esterified fatty acids
M2012: Cholesterol (total)
M2013: Cholesterol (HDL)
M2014: Cholesterol (LDL)
M2015: Ammonia
M2016: Lipase
M2018: Creatine kinase
M2019: Alkaline phosphatase
M2020: Lactate dehydrogenase
M2021: Albumin
M2022: Alanine transferase
M2023: Aspartate transferase
M2024: Bilirubin
M2025: Gamma-glutamyl Transferase
M2026: Creatinine
M2027: C-reactive peptide
M2028: Total protein
M2029: Urea/BUN
M2030: Uric acid
M2031: Electrolytes
M2032: Cytokines Panel I - multiplex
M2033: Cytokines Panel II - multiplex
D3495: MISC Assay
D3496: Corticosterone
V3071: Lipid extraction, separation, quantification
M2036: Cytokines Panel III - multiplex
D4003: Meal Pattern Analysis
D4008: Energy Expenditure (CLAMS, Indirect Calorimetry) + Meal Pattern Analysis
D4006-B: Gut Microbiome Analysis (454 method-10,000 avg seq read depth)
D4006-C: Gut Microbiome Analysis (Illumina method-2X300bp- 20,000 avg seq read depth)
D5101: Cognitive Function - Radial Arm Water Maze
D5102: Cognitive Function - Morris Water Maze (Male Mice)
D5104: Cognitive Function - Y Maze
D5106: Femoral Vein Cannulation
D5107: Blood Brain Barrier Permeability
D5201: IBA Immunohistochemistry
D5202: Factor VIII Immunohistochemistry
D4006-D: Gut Microbiome Analysis
D3414: Alanine Transaminase (ALT)
D3415: Aspartate Aminotransferase (AST)
V4026: Body Composition Analysis by NMR
M4002: Echocardiography
M1025: Drug trial study for PK/PD analysis
M1026: Drug trial study for therapeutic efficacy on obesity
M1027: Drug trial study for therapeutic efficacy on insulin resistance
M1028: Drug trial study for therapeutic efficacy on metabolic profile
M1030: Drug trial study for toxicity
D6001: Ex vivo assessment of barrier function/gut permeability (minimum of 8 samples)
D6002: Lipopolysaccharide Binding Protein (LBP)/Endotoxemia Assay
MI2029: Body Composition (Bruker Minispec LF 90II)
D4011: Voluntary wheel running (activity and/or exercise)
M1032: Body Weight
M2040: Glucagon-like peptide 1 (GLP-1 ).
Options:
View
Drag a column header and drop it here to group by that column
Name
Abbreviation
Units
Range
Protocol
Options
2-deoxyglucose AUC
None
0 to Infinity
None
acetoacetate oxidation
ACT OX
(µMol/min/g)
-Infinity to Infinity
None
Activity 24h (total vertical z-axis)
Activity 24h total z
(#beam breaks/24h)
-Infinity to Infinity
None
Activity 24h (total x-axis)
Activity 24h total x
(#beam breaks/24h)
-Infinity to Infinity
None
Activity 24h (total)
Activity 24h (total)
(#beam breaks/24h)
0 to Infinity
U Mass - Energy balance – food intake, energy expenditure, physical activity
Activity 24h (x-ambulatory)
Activity 24h (x-amb)
(#beam breaks/24h)
-Infinity to Infinity
None
adenosine diphosphate
adp
-Infinity to Infinity
None
adenosine monophosphate
AMP
-Infinity to Infinity
None
adenosine triphosphate
None
-Infinity to Infinity
None
adiponectin
None
(mg/dL)
-Infinity to Infinity
None
adiponectin, High Molecular Weight
adiponectin HMW
0 to 100
None
adiponectin, total
adiponectin total
(µg/ml)
0 to 100
None
Age
None
(w)
0 to 1092
None
Akt, phosphorylated
Akt phosphorylated
(AU)
0 to 10000
None
Akt, total
Akt total
(AU)
0 to 10000
None
alanine
None
0 to Infinity
None
Alanine transaminase, blood
None
0 to Infinity
U Mass - Alanine Transferase
alanine transferase
ALT
(U/L)
-Infinity to Infinity
None
albumin
None
(g/dL)
-Infinity to Infinity
None
albumin, blood
None
0 to Infinity
None
alkaline phosphatase, blood
None
0 to Infinity
None
alpha ketoglutarate glutamate exchange rate
Vx
(µMol/min/g)
-Infinity to Infinity
None
alternating triplets - percent
% triplets
(%)
0 to 100
UC Davis - Y-Maze
amino acids, branched-chain
None
0 to Infinity
None
amino acids, essential
None
0 to Infinity
None
amino acids, gluconeogenic
None
(U/L)
-Infinity to Infinity
None
amino acids, glyconeogenic
glyconeogenic AA
0 to Infinity
None
amino acids, nonessential
None
0 to Infinity
None
ammonia
ammonia
(µmol/l)
-Infinity to Infinity
None
anaplerosis
None
(µMol/min/g)
-Infinity to Infinity
None
Angiotensin II
Angiotensin II
(ng/ml)
0 to 1000
None
antibody
None
-Infinity to Infinity
None
antigen
None
-Infinity to Infinity
None
aortic lesion complexity index
LCI
-Infinity to Infinity
None
aortic pressure, mean
None
(mmHg)
-Infinity to Infinity
None
apolipoprotein A
None
(mg/dL)
-Infinity to Infinity
None
apolipoprotein B
None
(mg/dL)
-Infinity to Infinity
None
apolipoprotein C3
ApoC C3
(mg/dL)
0 to 800
None
aspartate
None
0 to Infinity
None
aspartate aminotransferase
AST
(U/L)
-Infinity to Infinity
None
Assay Respiratory Control
RC
-Infinity to Infinity
None
average aortic lesion area
AALA
(µm²)
0 to Infinity
None
average clamp glucose
None
(mg/dL)
-Infinity to Infinity
None
average glucose infusion rate
None
(mg/kg/min)
-Infinity to Infinity
None
beta-hydroxybutyrate
None
(µmol/l)
-Infinity to Infinity
None
beta-oxidation index
b-Ox index
(µMol/min/g)
-Infinity to Infinity
None
bicarbonte
None
(mEq/L)
-Infinity to Infinity
None
bilirubin
None
(mg/dL)
-Infinity to Infinity
None
bilirubin, blood
None
(mg/dL)
0 to Infinity
None
bilirubin, direct
None
(mg/dL)
-Infinity to Infinity
None
blood glucose
None
(mg/dL)
0 to Infinity
None
blood pressure, mean arterial
None
(mmHg)
-Infinity to Infinity
None
blood pressure: diastole
dBP
(mmHg)
0 to Infinity
Phenotypic Characterization of the Working Heart
blood pressure: mean arterial
aBP
(mmHg)
-Infinity to Infinity
None
blood pressure: systole
sBP
(mmHg)
0 to Infinity
Phenotypic Characterization of the Working Heart
body mass
W rodent
(g)
0 to 100
None
body water
body fluid
(g)
-Infinity to Infinity
None
body water, absolute amount
None
(g)
-Infinity to Infinity
None
body water, free
free water
(g)
-Infinity to Infinity
None
bone area
bone area
(cm²)
-Infinity to Infinity
None
bone mineral content
BMC
(g)
-Infinity to Infinity
None
bone mineral density
BMD
(g/cm²)
-Infinity to Infinity
None
Bout Distance, Average
Avg Bout Distance
(m/bout)
0 to 500
None
Bout Time, Average
Avg Bout Time
(min/bout)
0 to 10
None
Bouts
Bouts
(unitless)
0 to 1000
None
brain mass
brain wt
(g)
0 to 3
None
C-peptide
C-peptide
(ng/ml)
-Infinity to Infinity
None
c-reactive protein
CRP
(ng/ml)
0 to 25000
None
calcium
None
(mg/dL)
-Infinity to Infinity
None
calcium, blood
None
(mg/dL)
0 to Infinity
None
calcium, urine
urine calcium
(mg/dL)
1 to 15
None
carbon dioxide production
VCO2
(CO2/kg/hr)
-Infinity to Infinity
None
carbon dioxide production Dark Period
VCO2-D
(CO2/kg/hr)
-Infinity to Infinity
None
carbon dioxide production Light Period
VCO2-L
(CO2/kg/hr)
-Infinity to Infinity
None
carbon dioxide, blood
None
0 to Infinity
None
cardiac ejection fraction
None
(%)
0 to 100
None
cardiac function, intraventricular pressure: diastole
None
(mmHg)
-Infinity to Infinity
None
cardiac function, intraventricular pressure: end diastole
None
(mmHg)
-Infinity to Infinity
None
cardiac function, intraventricular pressure: systole
None
(mmHg)
-Infinity to Infinity
None
cardiac output
None
0 to Infinity
None
cardiac venous return
None
(ml/min)
-Infinity to Infinity
None
Catalase Activity
CAT Activity
(nmol/min/ml)
0 to 5000
None
Catalase Activity - protein
CAT Activity - prot
(nmol/min/mg protein)
0 to 5000
None
CCL11
Eotaxin
(pg/ml)
-Infinity to Infinity
None
CCL21
Exodus-2
(pg/ml)
0 to Infinity
None
chloride concentration
None
(U/kg)
-Infinity to Infinity
None
chloride, blood
None
0 to Infinity
None
chloride, urine
urine chloride
(µmol/l)
0 to Infinity
None
cholesterol
None
(mg/dL)
-Infinity to Infinity
None
cholesterol concentration in low density lipoproteins
None
(mg/dL)
-Infinity to Infinity
None
cholesterol concentration in very low density lipoproteins
None
(mg/dL)
-Infinity to Infinity
None
cholesterol remaining in intestinal lumen
None
(%)
-Infinity to Infinity
None
cholesterol remaining in intestinal lymph
None
(%)
-Infinity to Infinity
None
cholesterol remaining in intestinal mucosa
None
(%)
-Infinity to Infinity
None
Cholesterol transported in lymph
Cholesterol in lymph
(%)
-Infinity to Infinity
None
cholesterol, CM, plasma
CM-cholesterol
(mg/dL)
0 to 10000
None
cholesterol, fractional clearance rate
CHOL FCR
(min)
-Infinity to Infinity
None
cholesterol, HDL
None
(%)
-Infinity to Infinity
None
cholesterol, HDL (COBAS)
HDL-COBAS
(mg/dL)
0 to Infinity
None
cholesterol, HDL (UC)
HDL-UC
(mg/dL)
0 to Infinity
Ultracentrifugal separation of VLDL, LDL and HDL
cholesterol, HDL, plasma
HDL-cholesterol
(mg/dL)
-Infinity to Infinity
None
cholesterol, HDL, triglycerides, plasma
HDL-TG
(mg/dL)
-Infinity to Infinity
None
Cholesterol, Hepatic Uptake
Hepatic CHOL uptake
(%)
-Infinity to Infinity
None
cholesterol, LDL and VLDL
LDL/VLDL
(mg/dL)
0 to 5000
None
cholesterol, LDL, plasma
LDL-cholesterol
(mg/dL)
-Infinity to Infinity
None
cholesterol, newly synthesized
new cholesterol
(%)
0 to 100
None
cholesterol, splenic uptake
Splenic CHOL uptake
(%)
-Infinity to Infinity
None
cholesterol, TG-bound new
TG-bound cholesterol
(umol new/g tissue)
-Infinity to Infinity
None
cholesterol, TG-bound total
TG-bound cholesterol
(umol total/g tissue)
-Infinity to Infinity
None
cholesterol, tissue
cholesterol (tissue)
(mg/g tissue)
-Infinity to Infinity
None
cholesterol, vLDL, plasma
VLDL-cholesterol
(mg/dL)
-Infinity to Infinity
None
cholesteryl ester fatty acids
None
(%)
0 to 100
None
cholesteryl ester in chylomicrons
CE-CM
(% wt/wt)
-Infinity to Infinity
None
cholesteryl esters
None
(µg/mg)
0 to Infinity
None
chylomicrons
None
(%)
-Infinity to Infinity
None
citrate flux rate
None
(µMol/min/g)
-Infinity to Infinity
None
citrate synthase flux rate
citrate synthase FR
-Infinity to Infinity
None
CoA ester, C16:0
None
(nmol/g-tissue)
-Infinity to Infinity
None
CoA ester, C16:1
None
(nmol/g-tissue)
-Infinity to Infinity
None
CoA ester, C18:0
None
(nmol/g-tissue)
-Infinity to Infinity
None
CoA ester, C18:1
None
(nmol/g-tissue)
-Infinity to Infinity
None
CoA ester, C18:2
None
(nmol/g-tissue)
-Infinity to Infinity
None
CoA ester, C18:3
None
(nmol/g-tissue)
-Infinity to Infinity
None
CoA ester, total
TotalCoA
(nmol/g-tissue)
0 to Infinity
None
CoA esters, long-chain
None
(nmole)
-Infinity to Infinity
None
Complexes
None
(bpm)
0 to Infinity
None
corticosterone
None
(ng/ml)
-Infinity to Infinity
None
corticosterone, plasma, arterial
None
(µg/mg)
0 to Infinity
None
creatine kinase
creatine kinase
(U/L)
0 to Infinity
None
creatinine, blood
blood creatinine
(mg/dL)
0 to Infinity
None
creatinine, plasma
plasma cre
(mg/dL)
0 to Infinity
None
creatinine, serum
SCR
(mg/dL)
0 to Infinity
None
creatinine, urine (Exocell Picric Acid method)
ucreat
(mg/dL)
0 to Infinity
None
creatinine, urine (spot)
ucreatinine-spot
(mg/dL)
-Infinity to Infinity
None
creatinine, urine, 24h (HPLC)
UCreat-HPLC
(mg/dL)
-Infinity to Infinity
None
CX3CL1
Fractalkine
(pg/ml)
0 to Infinity
None
diacyglycerols
None
(µg/mg)
0 to Infinity
None
diacylglycerol fatty acids
None
(%)
0 to 100
None
Distance run
Distance run
(m)
0 to 20000
None
DR
D
-Infinity to Infinity
None
duration of recording
None
(min)
0 to Infinity
None
Duration run
Duration run
(min)
0 to 720
None
eating rate, average
avg eating rate
(g/min)
0 to Infinity
None
eating rate, dark
dark-eating rate
(g/min)
0 to Infinity
None
eating rate, light
light-eating rate
(g/min)
0 to Infinity
None
EKG-Beginning to end of QRS complex
EKG-QRS
(msec)
-Infinity to Infinity
None
EKG-Interval between R-waves
EKG-RR
(msec)
-Infinity to Infinity
None
EKG-Interval between the peak of P-wave to Q-wave
EKG-PQ
(msec)
-Infinity to Infinity
None
EKG-Interval between the peak of P-wave to R-wave
EKG-PR
(msec)
-Infinity to Infinity
None
EKG-Interval between the peak of Q-wave to end of T-wave
EKG-QT
(msec)
-Infinity to Infinity
None
EKG-Interval between the peak of S-wave to end of T-wave
EKG-ST
(msec)
-Infinity to Infinity
None
EKG-Rate-corrected QT
EKG-QTc
(msec)
-Infinity to Infinity
None
endurance time
None
(min)
0 to Infinity
None
energy expenditure
None
(kcal/hr/kg)
-Infinity to Infinity
None
energy expenditure, 30 min exercise
None
0 to Infinity
None
energy expenditure, basal
None
0 to Infinity
None
energy expenditure, exhaustion
None
0 to Infinity
None
energy expenditure, maximum
None
0 to Infinity
None
energy intake (24 hr)
None
(Kcal/day)
-Infinity to Infinity
None
energy intake (avg 24 hr)
energy intake avg 24
(Kcal/day)
-Infinity to Infinity
None
energy intake (Dark Period)
energy intake - dark
(Kcal/12h)
-Infinity to Infinity
None
energy intake (Light Period)
food intake - light
(g/12h)
0 to Infinity
None
energy intake (Ligth Period)
energy intake -light
(Kcal/12h)
-Infinity to Infinity
None
epinephrine, plasma, arterial
None
0 to Infinity
None
Erythropoietin
EPO
(pg/ml)
0 to Infinity
None
exploratory activity
None
0 to Infinity
None
fat absorbtion, dietary
None
(%)
-Infinity to Infinity
None
fat body mass
None
(g)
0 to Infinity
None
fat tissue mass
None
(g)
-Infinity to Infinity
None
fat tissue, %
% body fat
(%)
0 to 100
None
fat tissue, brown
BAT wt
(g)
0 to 7
None
fat tissue, epidymal
epidymal fat wt
(g)
0 to 7
None
fat tissue, mesenteric
Mesenteric Fat Wt
(g)
0 to 7
None
fat tissue, periovarian
PFD wt
(g)
0 to 7
None
fat tissue, retroperitoneal
retroperitoneal fat
(g)
0 to 7
None
fat tissue, subcutaneous
subcutaneous fat wt
(g)
0 to 7
None
Fecal Output
None
(g)
-Infinity to Infinity
None
Fibroblast growth factor 21
FGF-21
(pg/ml)
0 to 50000
None
FITC-Dextran 4000 (FD4) flux
FD4 flux
(ng/cm2/h)
0 to Infinity
UC Davis - Ex vivo assessment of barrier function-gut permeability
food intake
food intake
(g/day)
0 to Infinity
None
food intake (Dark Period)
food intake - dark
(g/12h)
-Infinity to Infinity
None
food intake to body weight ratio
food intake/bw
0 to Infinity
None
fractional shortening
None
0 to Infinity
Echocardiography: Mouse
free fatty acids, tissues
FFA tissue
(mEq/g tissue)
0 to 100
None
GABA and glutamate
None
0 to Infinity
None
Gamma-glutamyl Transpeptidase
GGT
(U/L)
0 to 50
None
ghrelin, active
ghrelin active
(pg/ml)
0 to 1000
None
ghrelin, total
ghrelin total
(pg/ml)
0 to 10000
None
GIP
GIP
(ng/ml)
-Infinity to Infinity
None
glomerular filtration rate
GFR
(ml/min)
-Infinity to Infinity
None
glucagon
None
(pg/ml)
-Infinity to Infinity
None
glucagon, plasma, arterial
None
0 to Infinity
None
Glucagon-like peptide 1
GLP-1
(ng/ml)
-Infinity to Infinity
None
glucagon-like peptide-1, active
GLP-1 active
(pg/ml)
0 to 1000
None
glucagon-like peptide-1, total
GLP-1 total
(pg/ml)
0 to 1000
None
gluconeogenesis
GNGtotal
(µMol/min/g)
-Infinity to Infinity
None
gluconeogenesis from glycerol
GNGglycerol
(µMol/min/g)
-Infinity to Infinity
None
gluconeogenesis from PEP
GNGpep
(µMol/min/g)
-Infinity to Infinity
None
gluconeogenesis rate
None
(mg/kg/min)
0 to Infinity
None
glucose appearance, endogenous
None
-Infinity to Infinity
None
glucose infusion rate
None
-Infinity to Infinity
None
glucose infusion rates
None
(mg/kg/min)
0 to Infinity
None
glucose metabolic index, brain
None
0 to Infinity
None
glucose metabolic index, diaphragm
None
0 to Infinity
None
glucose metabolic index, gastrocnemius
None
0 to Infinity
None
glucose metabolic index, heart
None
-Infinity to Infinity
None
glucose metabolic index, soleus
None
0 to Infinity
None
glucose metabolic index, superficial vastus lateralis
None
0 to Infinity
None
glucose oxidation
None
(µMol/min/g)
-Infinity to Infinity
None
glucose production
None
(µMol/min/g)
-Infinity to Infinity
None
glucose rate of appearance, endogenous
endo RA
(mg/kg/min)
-Infinity to Infinity
None
glucose rate of disappearance
None
-Infinity to Infinity
None
glucose synthesis
None
(nmol/min/g)
-Infinity to Infinity
None
glucose tolerance test (AUC)
GTT-AUC
(mg/dl*min)
10000 to 100000
None
glucose turnover, whole body
None
(mg/kg/min)
-Infinity to Infinity
None
glucose uptake
None
(nmol/min/g)
-Infinity to Infinity
Glucose uptake in isolated cardiomyocytes.
glucose uptake, brown fat
glucose uptake brown
(nmole/g/min)
0 to Infinity
None
glucose uptake, heart
glucose uptake heart
(nmole/g/min)
0 to Infinity
None
glucose uptake, muscle
glucose uptake muscl
(nmole/g/min)
0 to Infinity
None
glucose uptake, white adipose
glucose uptake white
(nmole/g/min)
0 to Infinity
None
glucose, arterial
None
(mg/dL)
-Infinity to Infinity
None
glucose, basal
None
(mg/dL)
-Infinity to Infinity
None
glucose, blood, arterial
None
-Infinity to Infinity
None
glucose, clamp average
None
(mg/dL)
-Infinity to Infinity
None
glucose, plasma
plasma glucose
(mg/dL)
0 to Infinity
None
glucose, rate of appearance, endogenous
RA
(mg/kg/min)
-Infinity to Infinity
None
glucose, rate of disappearance
Rd
(mg/kg/min)
-Infinity to Infinity
None
glucose, urine
None
(mg/dL)
0 to Infinity
None
glutamate
None
0 to Infinity
None
glutamine
None
0 to Infinity
None
glutamine dehydrogenase
GLDH
(U/L)
0 to Infinity
None
glutamine rate of appearance in blood
None
0 to Infinity
None
glutamine rate of disappearance in blood
None
0 to Infinity
None
glutamine, blood, arterial
None
0 to Infinity
None
Glutathione Peroxidase Activity
GP Activity
(nmol/min/ml)
0 to 5000
None
Glutathione Peroxidase Activity - protein
GPA-protein
(nmol/min/mg protein)
0 to 1000
None
Glutathione Reductase Activity
GR Activity
(nmol/min/ml)
0 to 5000
None
Glutathione Reductase Activity - protein
GRA-protein
(nmol/min/mg protein)
0 to 1000
None
glycerol
None
(µMol/min/g)
-Infinity to Infinity
None
glycerol flux rate
glycerol FR
-Infinity to Infinity
None
glycerol fraction
glycerol fraction
-Infinity to Infinity
None
glycerol, plasma
None
(mg/dL)
0 to 100
None
glycerol, TG-bound new
TG-bound glycerol ne
(umol new/g tissue)
-Infinity to Infinity
None
glycerol, TG-bound total
TG-bound glycerol to
(umol total/g tissue)
-Infinity to Infinity
None
glycerol, total labeled
glycerol total label
(%)
0 to 100
None
glycine
None
0 to Infinity
None
glycogen synthesis
None
(nmol/min/g)
-Infinity to Infinity
None
glycogen concentration
glycogen conc
0 to Infinity
None
glycogen flux rate
glycogen FR
-Infinity to Infinity
None
glycogen fraction
glycogen fraction
-Infinity to Infinity
None
glycogen, gastrocnemius
None
-Infinity to Infinity
None
glycogen, heart
None
-Infinity to Infinity
None
glycogen, liver
None
0 to Infinity
None
glycogen, muscle
None
-Infinity to Infinity
None
glycogen, superficial vastus lateralis
None
0 to Infinity
None
glycogen/lipid synthesis, whole body
None
(mg/kg/min)
-Infinity to Infinity
None
glycogenolysis, rate
GLY
(µMol/min/g)
-Infinity to Infinity
None
glycogenolytic rate
None
(mg/kg/min)
0 to Infinity
None
glycolysis
None
(nmol/min/g)
-Infinity to Infinity
None
glycolysis, whole body
None
(mg/kg/min)
-Infinity to Infinity
None
Granulocyte colony stimulating factor
G-CSF
(pg/ml)
-Infinity to Infinity
None
HbA1c
HbA1c
(%)
0 to 100
None
heart mass
cardiac muscle weigh
(g)
0 to 3
None
heart rate
HR
(bpm)
0 to Infinity
Phenotypic Characterization of the Working Heart
heart, mass
None
(g)
0 to Infinity
None
heat
HEAT
(Kcal/hr)
-Infinity to Infinity
None
heat (24hr)
heat - 24h
(Kcal/day)
-Infinity to Infinity
None
heat (Dark Period)
HEAT-Dark
(Kcal/hr)
-Infinity to Infinity
None
heat (Light Period)
HEAT-Light
(Kcal/hr)
-Infinity to Infinity
None
hematocrit
Hct
0 to Infinity
None
hematocrit, arterial
None
(%)
-Infinity to Infinity
None
Hematocrit, HCT
None
(%)
0 to 100
None
hepatic glucose production
HPG
(µMol/min/g)
-Infinity to Infinity
None
hepatic glucose production, basal
None
(mg/kg/min)
-Infinity to Infinity
None
Hepatic Glucose Production, clamp
None
(mg/kg/min)
-Infinity to Infinity
None
hepatic insulin action
HIA
(%)
0 to 100
None
Histidine
None
0 to Infinity
None
Horseradish peroxidase (HRP) flux
HRP flux
(ng/cm2/h)
0 to Infinity
UC Davis - Ex vivo assessment of barrier function-gut permeability
immunohistochemistry - BODIPY
IHC-BODIPY
(intensity (AU))
0 to Infinity
UC Davis - Immunohistochemistry BODIPY
immunohistochemistry - Factor VIII
IHC-Factor VIII
(density (AU))
0 to Infinity
UC Davis - Immunohistochemistry Factor VIII
immunohistochemistry - IBA1
IHC-IBA1
(density (AU))
0 to Infinity
UC Davis - Immunohistochemistry IBA1
immunohistochemistry - Mitochondrial Marker
IHC-Mito Marker
(density (AU))
0 to Infinity
UC Davis - Immunohistochemistry Mitochondrial marker
Insulin 16.8 mM glucose
None
0 to Infinity
None
Insulin 16.8 mM glucose + IBMX
None
0 to Infinity
None
Insulin 5.6 mM glucose
None
0 to Infinity
None
Insulin 5.6 mM glucose + tollbutamide
None
0 to Infinity
None
insulin dose
None
(µMol/min/g)
-Infinity to Infinity
None
insulin receptor substrate 1, phosphorylated
IRS-1 phosphorylated
(AU)
0 to 10000
None
insulin receptor substrate 1, total
IRS-1 total
(AU)
0 to 10000
None
insulin, arterial
None
(mg/dL)
-Infinity to Infinity
None
insulin, basal
None
(ng/ml)
0 to Infinity
None
insulin, blood
None
(ng/dl)
0 to Infinity
None
insulin, clamp
None
(ng/ml)
0 to Infinity
None
insulin, experimental
None
-Infinity to Infinity
None
insulin, plasma
None
(pg/ml)
5 to 500000
None
insulin, plasma, arterial
None
0 to Infinity
None
insulin, serum
S Insulin
0 to Infinity
None
Insulin-like Growth Factor-1
IGF-1
(ng/ml)
0 to 1000
None
inter-meal interval, average
avg IMI
(sec)
0 to Infinity
None
inter-meal interval, average dark
avg dark-IMI
(sec)
0 to Infinity
None
inter-meal interval, average light
avg light-IMI
(sec)
0 to Infinity
None
Interferon gamma
IFNg
(pg/ml)
0 to Infinity
None
Interferon gamma-induced protein 10 (CXCL-10)
IP-10
(pg/ml)
0 to Infinity
None
Interleukin 1 alpha
IL-1a
(pg/ml)
0 to Infinity
None
Interleukin 1 beta
IL-1ß
(pg/ml)
0 to Infinity
None
Interleukin 10
IL-10
(pg/ml)
0 to Infinity
None
Interleukin 12 (p40)
IL-12 (p40)
(pg/ml)
0 to Infinity
None
Interleukin 12 (p70)
IL-12 (p70)
(pg/ml)
0 to Infinity
None
Interleukin 13
IL-13
(pg/ml)
0 to Infinity
None
Interleukin 15
IL-15
(pg/ml)
0 to Infinity
None
Interleukin 16
IL-16
(pg/ml)
0 to Infinity
None
Interleukin 17A
IL-17A
(pg/ml)
0 to Infinity
None
Interleukin 17E / Interleukin 25
IL-17E/IL-25
(pg/ml)
0 to Infinity
None
Interleukin 2
IL-2
(pg/ml)
0 to Infinity
None
Interleukin 20
IL-20
(pg/ml)
0 to Infinity
None
Interleukin 21
IL-21
(pg/ml)
0 to Infinity
None
Interleukin 22
IL-22
(pg/ml)
0 to Infinity
None
Interleukin 23
IL-23
(pg/ml)
0 to Infinity
None
Interleukin 27
IL-27
(pg/ml)
0 to Infinity
None
Interleukin 28B
IL-28B
(pg/ml)
0 to Infinity
None
Interleukin 3
IL-3
(pg/ml)
0 to Infinity
None
Interleukin 33
IL-33
(pg/ml)
0 to Infinity
None
Interleukin 4
IL-4
(pg/ml)
0 to Infinity
None
Interleukin 5
IL-5
(pg/ml)
0 to Infinity
None
Interleukin 6
IL-6
(pg/ml)
0 to Infinity
None
Interleukin 7
IL-7
(pg/ml)
0 to Infinity
None
Interleukin 8 homologue
KC
(pg/ml)
0 to Infinity
None
Interleukin 9
IL-9
(pg/ml)
0 to Infinity
None
Iron
Iron
(µg/dl)
0 to 1000
None
isoleucine
None
0 to Infinity
None
ketogenesis
ketogenesis
(µMol/min/g)
-Infinity to Infinity
None
ketoisocaproic, blood, arterial
None
0 to Infinity
None
ketones, urine
urine ketones
-Infinity to Infinity
None
Kf, brain
None
0 to Infinity
None
Kf, diaphragm
None
0 to Infinity
None
Kf, diaphragms
None
0 to Infinity
None
Kf, gastrocnemius
None
0 to Infinity
None
Kf, heart
None
0 to Infinity
None
Kf, soleus
None
0 to Infinity
None
Kf, superficial vastus laterlis
None
0 to Infinity
None
Kg, adipose
None
(ml/100g/min)
0 to Infinity
None
Kg, brain
None
(ml/100g/min)
0 to Infinity
None
Kg, diaphragm
None
(ml/100g/min)
0 to Infinity
None
Kg, gastrocnemius
None
(ml/100g/min)
0 to Infinity
None
Kg, heart
None
(ml/100g/min)
0 to Infinity
None
Kg, soleus
None
(ml/100g/min)
0 to Infinity
None
Kg, superficial vastus lateralis
None
(ml/100g/min)
0 to Infinity
None
Kg, vastus lateralis
None
(ml/100g/min)
-Infinity to Infinity
None
kidney glomerular size
GlomerularSize
(µm²)
-Infinity to Infinity
None
kidney matrix area
kidney matrix area
(µm²)
-Infinity to Infinity
None
kidney percent matrix
kidney percent matri
(%)
0 to 100
None
kidney, long-axis area
None
(cm)
0 to Infinity
None
kidney, long-axis area, right
right kidney LAArea
(cm)
0 to Infinity
None
kidney, long-axis circle
None
(cm)
0 to Infinity
None
kidney, long-axis circle, right
right kidney LACircl
(cm)
0 to Infinity
None
kidney, long-axis HGT
None
(cm)
0 to Infinity
None
kidney, long-axis HGT, right
right kidney LAHGT
(cm)
0 to Infinity
None
kidney, long-axis LGT
None
(cm)
0 to Infinity
None
kidney, long-axis LGT, right
right kidney LALGT
(cm)
0 to Infinity
None
kidney, short-axis area, right
right kidney SAArea
(cm)
0 to Infinity
None
kidney, short-axis circle
None
(cm)
0 to Infinity
None
kidney, short-axis circle, right
right kidney SACircl
(cm)
0 to Infinity
None
kidney, short-axis HGT
None
(cm)
0 to Infinity
None
kidney, short-axis HGT, right
right kidney SAHGT
(cm)
0 to Infinity
None
kidney, short-axis LGT
None
(cm)
0 to Infinity
None
kidney, short-axis WDT
None
(cm)
0 to Infinity
None
kidney, short-axis WDT, right
right kidney SAWDT
(cm)
0 to Infinity
None
L-Lactate
L-Lactate
(mg/dL)
0 to 100
None
lactate
lactate
(mmol/L)
1 to 50
None
lactate dehydrogenase
lactate dehydrogenas
(U/L)
0 to Infinity
None
latency
latency
(sec)
0 to 90
UC Davis - Morris Water Maze
lean body mass
None
(g)
-Infinity to Infinity
None
lean tissue mass
None
(g)
-Infinity to Infinity
None
lean tissue, %
% lean mass
(%)
0 to 100
None
left atrial pressure
None
(mmHg)
-Infinity to Infinity
None
left ventricle interior diameter, end systoloic
LVID-end systoloic
(mm)
0 to Infinity
None
left ventricle anterior wall thickness, end diastolic
LVAWT-end diastolic
(mm)
0 to Infinity
None
left ventricle chamber diameter end diastolic
None
(mm)
-Infinity to Infinity
None
left ventricle chamber diameter end systolic
None
(mm)
-Infinity to Infinity
None
left ventricle interior diameter, end diastolic
LVID-end diastolic
0 to Infinity
None
left ventricle internal diameter end-diastole
None
(cm)
0 to Infinity
None
left ventricle internal diameter end-systole
None
(cm)
0 to Infinity
None
left ventricle mass
None
(g)
0 to Infinity
None
left ventricle posterior wall thickness end diastolic
LVPWT-end diastolic
(mm)
-Infinity to Infinity
None
left ventricle posterior wall thickness end systolic
LVPWT-end systolic
(mm)
-Infinity to Infinity
None
left ventricle posterior wall thickness end-diastole
LVPWT-end diaastole
(cm)
0 to Infinity
None
left ventricle posterior wall thickness end-systole
LVPWT-end systole
(cm)
0 to Infinity
None
left ventricle septal wall thickness end-diastole
LVSWT-end diastole
(cm)
0 to Infinity
None
left ventricle septal wall thickness end-systole
LVSWT-end systole
(cm)
0 to Infinity
None
left ventricle septum wall thickness end diastolic
LVSWT-end diastole
(mm)
-Infinity to Infinity
None
left ventricle septum wall thickness end systolic
LVSWT-end systolic
(mm)
-Infinity to Infinity
None
left ventricular minute work
LV Minute work
(mEq/L)
-Infinity to Infinity
None
leptin
None
(ng/dl)
-Infinity to Infinity
None
leptin (RIA)
Leptin
0 to Infinity
None
leucine
None
0 to Infinity
None
leucine appearance reciprocal model rate
None
0 to Infinity
None
leucine disappearance rate
None
0 to Infinity
None
leucine, blood, arterial
None
0 to Infinity
None
Leukemia inhibitory factor
LIF
(pg/ml)
0 to Infinity
None
linoleate, tissue
linoleate (tissue)
(mg/g tissue)
-Infinity to Infinity
None
lipids, blood
None
(mg/dL)
0 to Infinity
None
lipids, tissue
lipids tissue
(%)
0 to Infinity
None
lipopolysaccharide binding protein (LBP) concentration
LBP conc
(µg/ml)
0 to Infinity
UC Davis - Lipoprotein Binding Protein (LBP)-Endotoxemia Assay
lipoprotein, intermediate density
None
0 to Infinity
None
lipoproteins, alpha
None
(%)
-Infinity to Infinity
None
lipoproteins, beta
None
(%)
-Infinity to Infinity
None
lipoproteins, LDL
None
0 to Infinity
None
lipoproteins, pre-beta
None
(%)
-Infinity to Infinity
None
liver mass
Liver Wt
(g)
0 to 6
None
LPS-induced CXC chemokine
LIX
(pg/ml)
0 to Infinity
None
lymph flow
lymph flow
(ml/hr)
-Infinity to Infinity
None
Lysine
None
0 to Infinity
None
Macrophage colony stimulating factor
M-CSF
(pg/ml)
0 to Infinity
None
macrophage colony stimulating factor, granulocyte
GM-CSf
(pg/ml)
-Infinity to Infinity
None
Macrophage inflammatory protein 2-alpha (CXCL2)
MIP-2/RANTES
(pg/ml)
0 to Infinity
None
Macrophage inflammatory protein 3-alpha (CCL20)
MIP-3a
(pg/ml)
0 to Infinity
None
Macrophage inflammatory protein 3-beta (CCL19)
MIP-3ß
(pg/ml)
0 to Infinity
None
Macrophage inflammatory protein alpha (CCL3)
MIP-1a
(pg/ml)
0 to Infinity
None
Macrophage inflammatory protein beta (CCL4)
MIP-1ß
(pg/ml)
0 to Infinity
None
Macrophage-derived chemokine (CCL22)
MDC
(pg/ml)
0 to Infinity
None
magnesium
None
(mEq/L)
-Infinity to Infinity
None
mammary gland mass
Mammary wt
(g)
0 to 3
None
maze errors
maze errors
1 to 15
UC Davis - Radial Arm Water Maze
meal duration (Avg) - Active Eating Time
avg meal dur AET
(sec)
0 to Infinity
None
meal duration (total)
total meal duration
(sec)
0 to Infinity
None
meal duration, average dark
avg dark-meal dur
(sec)
0 to Infinity
None
meal duration, average light
avg light-meal dur
(sec)
0 to Infinity
None
meal size (Avg)
avg meal size
(g)
0 to Infinity
None
meal size, average dark
avg dark-meal size
(g)
0 to Infinity
None
meal size, average light
avg light-meal size
(g)
0 to Infinity
None
meals, number
num meals
-Infinity to Infinity
None
meals, number dark
dark-num meals
-Infinity to Infinity
None
meals, number light
light-num meals
0 to Infinity
None
mesangial index
PAS
(%PAS/glom)
0 to 100
None
methionine
None
0 to Infinity
None
Monocyte chemotactic protein-1 (CCL2)
MCP-1
(pg/ml)
0 to Infinity
None
Monocyte chemotactic protein-5 (CCL12)
MCP-5
(pg/ml)
0 to Infinity
None
Monokine induced by gamma interferon (CXCL9)
MIG
(pg/ml)
0 to Infinity
None
muscle mass, skeletal
skeletal muscle weig
(g)
0 to 3
None
NEFA
FFA
-Infinity to Infinity
None
NEFA oxidation
None
(umol/min/g)
-Infinity to Infinity
None
NEFA oxidation, free
FFA OX
(µMol/min/g)
-Infinity to Infinity
None
NEFA, arterial
None
0 to Infinity
None
NEFA, in chylomicrons
FFA in CM
(% wt/wt)
-Infinity to Infinity
None
NEFA, plasma
None
-Infinity to Infinity
None
NEFA, plasma, arterial
apNEFA
-Infinity to Infinity
None
NEFA, plasma, arterial, clamp
None
-Infinity to Infinity
None
NEFA, plasma, arterial, fatty acids
None
-Infinity to Infinity
None
NEFA, short-chain
None
(µg/mg)
0 to Infinity
None
neointimal hyperplasia
Neo Hyperplasia
(µm²)
0 to Infinity
None
non-esterified free fatty acids
NEFA
(µmol/l)
0 to Infinity
None
norepinephrine, plasma, arterial
None
0 to Infinity
None
octanoate oxidation
OCT OX
(µMol/min/g)
-Infinity to Infinity
None
oleate, tissue
oleate (tissue)
(mg/g tissue)
-Infinity to Infinity
None
osmolality
None
(fL)
-Infinity to Infinity
None
oxygen consumption
VO2
(O2/kg/hr)
-Infinity to Infinity
None
oxygen consumption (Dark Period)
VO2-D
(O2/kg/hr)
-Infinity to Infinity
None
oxygen consumption (Light Period)
VO2-L
(O2/kg/hr)
-Infinity to Infinity
None
palmitate, TG-bound new
TG-bound plamitate n
(umol new/g tissue)
-Infinity to Infinity
None
palmitate, TG-bound total
TG-bound palmitate t
(umol total/g tissue)
-Infinity to Infinity
None
palmitate, TG-bound, newly sythesized
TG-bound palmitate N
(%)
0 to 100
None
palmitate, tissue
palmitate (tissue)
(mg/g tissue)
-Infinity to Infinity
None
PEPCK
None
(µMol/min/g)
-Infinity to Infinity
None
Permeability
Ki
(min^-1)
0 to 1
None
phenylalanine
None
0 to Infinity
None
phenylalanine appearance in blood rate
None
0 to Infinity
None
phenylalanine disappearance rate
None
0 to Infinity
None
phenylalanine, blood, arterial
None
0 to Infinity
None
phosphate, blood
None
(mg/dL)
0 to Infinity
None
phosphate, blood, inorganic
blood inorganic phos
(mg/dL)
0 to Infinity
None
phosphate, urine
urine inorganic phos
(mg/dL)
0 to Infinity
None
Phosphatidyl choline
None
(µg/mg)
0 to Infinity
None
phosphatidyl ethanolamine
None
(µg/mg)
0 to Infinity
None
Phosphatidyl serine
None
(µg/mg)
0 to Infinity
None
phosphoenolpyruvate
None
(µMol/min/g)
-Infinity to Infinity
None
Phosphoenolpyruvate carboxykinase flux rate
PEPCK FR
-Infinity to Infinity
None
phosphoenolpyruvate flux rate
PEP FR
-Infinity to Infinity
None
phosphoenolpyruvate fraction
PEP fraction
-Infinity to Infinity
None
phospholipid
None
(mg/dL)
-Infinity to Infinity
None
phospholipid fatty acids
None
(%)
0 to 100
None
phospholipids, chylomicrons
PL-CM
(% wt/wt)
-Infinity to Infinity
None
potassium, blood
None
0 to Infinity
None
potassium, urine
urine postassium
(µmol/l)
0 to Infinity
None
pressure development, maximal rate
None
-Infinity to Infinity
None
proline
None
(µmol/l)
-Infinity to Infinity
None
protein
None
(g/dL)
-Infinity to Infinity
None
Protein Carbonyl
Protein Carbonyl
(nmol/ml)
0 to 1000
None
Protein Carbonyl - protein
P Carbonyl - protein
(nmol/mg)
0 to 1000
None
protein, chylomicrons
Protein-CM
(% wt/wt)
-Infinity to Infinity
None
protein, total blood
None
0 to Infinity
None
pulse
None
(bpm)
0 to Infinity
None
pyruvate cycling flux rate
PC FR
-Infinity to Infinity
None
pyruvate oxidation
PYRV OX
(ng/ml)
-Infinity to Infinity
None
relaxation, maximal rate
None
-Infinity to Infinity
None
Resistin
None
(ng/ml)
-Infinity to Infinity
None
Respiratory Control
RC
-Infinity to Infinity
Evaluation of Mitochondrial Function
respiratory exchange ratio
RQ
-Infinity to Infinity
None
respiratory exchange ratio (Dark Period)
RER-D
-Infinity to Infinity
None
respiratory exchange ratio (Light Period)
RER-L
0 to Infinity
None
respiratory exchange ratio, maximum
RQ-Max
(AU)
0.6 to 1.2
None
respiratory exchange ratio, minimum
RQ-Min
(AU)
0.6 to 1.2
None
Rg, adipose
None
(umol/100g/min)
0 to Infinity
None
Rg, brain
None
(umol/100g/min)
0 to Infinity
None
Rg, diaphragm
None
(umol/100g/min)
0 to Infinity
None
Rg, gastrocnemeous
None
(umol/100g/min)
0 to Infinity
None
Rg, heart
None
(umol/100g/min)
0 to Infinity
None
Rg, soleus
None
(umol/100g/min)
0 to Infinity
None
Rg, vastus lateralis
None
(umol/100g/min)
0 to Infinity
None
Sample Weight
sample weight
(mg)
-Infinity to Infinity
None
satiety ratio
satiety ratio
0 to Infinity
None
satiety ratio, dark
dark-satiety ratio
-Infinity to Infinity
None
satiety ratio, light
light-satiety ratio
0 to Infinity
None
serines
None
0 to Infinity
None
serum glutamic pyruvic transaminase
None
0 to Infinity
None
sodium, blood
None
0 to Infinity
None
sodium, urine
urine sodium
(µmol/l)
0 to Infinity
None
Somatostatin
Somatostatin
(pg/ml)
-Infinity to Infinity
None
sphingomyelin
None
(µg/mg)
0 to Infinity
None
sterate
sterate (tissue)
(mg/g tissue)
-Infinity to Infinity
None
sterol synthesis
None
-Infinity to Infinity
None
Stomach Mass
Stomach Mass
(g)
0 to 5
None
Superoxide Dismutase Activity
SOD Actvity
(u/ml)
0 to 5000
None
Superoxide Dismutase Activity - protein
SOD Activity - prot
(U/mg protein)
0 to 5000
None
TAQ
A
-Infinity to Infinity
None
TCA cycle flux
VTCA
(µMol/min/g)
-Infinity to Infinity
None
temperature, body
body temp
(°C)
25 to 45
None
temperature, environmental
ENV TEMP
(°C)
3 to 40
None
threonine
None
0 to Infinity
None
Thymus and activation-regulated (CCL17)
TARC
(pg/ml)
0 to Infinity
None
time in platform/border zone
time in zone
(sec)
0 to 90
UC Davis - Morris Water Maze
Time to Peak Pressure
None
(10^3/mm3)
-Infinity to Infinity
None
tissue area
tissue area
(cm²)
-Infinity to Infinity
None
Tissue-inhibitor of metalloproteinases
TIMP-1
(pg/ml)
0 to Infinity
None
total activity
None
0 to Infinity
None
total body weight
None
(g)
-Infinity to Infinity
None
total cholesterol
TC
(mg/dL)
0 to Infinity
Lipid Profiles in Mice
total distance
TD
(m)
0 to 50000
None
total tissue mass
TTM
(g)
-Infinity to Infinity
None
Transforming growth factor beta 1
TGF-B1
(ng/ml)
0 to 1000
None
triglyceride in LDL and VLDL
TG in LDL/VLDL
(mg/dL)
0 to 2000
None
triglyceride pool enrichment
TG POOL
-Infinity to Infinity
None
triglyceride remaining in intestinal lumen
TG in IL
(%)
-Infinity to Infinity
None
triglyceride remaining in intestinal mucosa
TG in IM
(%)
-Infinity to Infinity
None
triglyceride transported in lymph
TG in Lymph
(%)
-Infinity to Infinity
None
triglyceride, CM
TG in CM
(mg/dL)
0 to 10000
None
triglyceride, fatty acids
TGFA
(%)
0 to 100
None
triglyceride, fractional clearance rate
TG FCR
(min)
-Infinity to Infinity
None
triglyceride, HDL
TG in HDL
(mg/dL)
-Infinity to Infinity
None
triglyceride, hepatic uptake
Hepatic TG uptake
(% wt/wt)
-Infinity to Infinity
None
triglyceride, LDL
TG in LDL
(mg/dL)
-Infinity to Infinity
None
triglyceride, newly synthesized
new triglyceride
(%)
0 to 100
None
triglyceride, splenic uptake
Splenic TG uptake
(U/L)
-Infinity to Infinity
None
triglyceride, TG-bound new
TG-bound triglycerid
(umol new/g tissue)
-Infinity to Infinity
None
triglyceride, TG-bound total
TG-bound triglycerid
(umol total/g tissue)
-Infinity to Infinity
None
triglyceride, vLDL
TG in VLDL
(mg/dL)
-Infinity to Infinity
None
triglycerides
TG
(mg/dL)
-Infinity to Infinity
None
triglycerides in organ through extraction & determination
None
(U/L)
-Infinity to Infinity
None
triglycerides, tissue
TG (tissue)
(mg/g tissue)
-Infinity to Infinity
None
Troponin I (cardiac)
Troponin I - cardiac
(ng/ml)
0 to 1000
None
Troponin T
Troponin T
(pg/ml)
0 to 1000
None
Tumor necrosis factor alpha
TNFa
(pg/ml)
0 to Infinity
None
tyrosines
None
0 to Infinity
None
unesterified cholesterol
None
(µg/mg)
0 to Infinity
None
unesterified fatty acids
None
(µg/mg)
0 to Infinity
None
urea nitrogen, blood
BUN
(mg/dL)
0 to Infinity
None
urine output
urine output
(ml)
-Infinity to Infinity
None
urine pH
urine pH
0 to 14
None
valine
None
0 to Infinity
None
Vascular endothelial growth factor
VEGF
(pg/ml)
0 to Infinity
None
VCO2 (Dark)
VCO2-D
(CO2/kg/hr)
0 to Infinity
None
VCO2 (Light)
VCO2-L
(CO2/kg/hr)
0 to Infinity
None
VCO2 30 Min Exercise
None
0 to Infinity
None
VCO2 basal
None
0 to Infinity
None
VCO2 exhaustion
None
0 to Infinity
None
VCO2 max
None
0 to Infinity
None
VCO2 rate
VCO2 rate
(ml/hr/kg)
0 to Infinity
None
Velocity run
Velocity run
(m/min)
0 to 50
None
VO2 (Dark)
VO2-D
(O2/kg/hr)
0 to Infinity
None
VO2 (Light)
VO2-L
(O2/kg/hr)
0 to Infinity
None
VO2 30 min exercise
None
0 to Infinity
None
VO2 basal
None
0 to Infinity
None
VO2 Exhaustion
None
0 to Infinity
None
VO2 max
None
0 to Infinity
None
VO2 rate
VO2 rate
(ml/hr/kg)
0 to Infinity
None
VO2, maximum
None
-Infinity to Infinity
None
water intake
water intake
(ml/kg/hr)
0 to 4
None
wheel running day
None
0 to Infinity
None
Work Duration
None
(min)
0 to Infinity
None
WR max
None
0 to Infinity
None
Back to Top
Safari Browser Detected...
I see you are using a
Safari browser
to navigate our site.
We strive to make the MMPC site compatable with as many browsers as possible, but some of our third party tools don't work with the Safari browser.
In order to explore this site we highly recommend using the most recent versions of the following browsers:
Internet Explorer
Google Chrome
FireFox